Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2022
Title: Min Ji - Innovator in Pharmaceutical Modulation
Introduction
Min Ji is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of indoleamine 2,3-dioxygenase. His work focuses on developing compounds that can be used in treating various diseases, including cancers and neurodegenerative disorders.
Latest Patents
Min Ji holds a patent for a "Modulator of indoleamine 2,3-dioxygenase, preparation method and use thereof." This invention relates to a modulator of 1,2,5-oxadiazole indoleamine-(2,3)-dioxygenase. The patent details compounds of Formula I and Formula II, including their isomers, pharmaceutically acceptable salts, and solvates. These compounds are intended for use in preparing drugs for treating a range of conditions, such as cancers, mental disorders, and autoimmune diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Min Ji has worked with prominent pharmaceutical companies, including Nanjing Carephar Shenghui Pharmaceutical Co., Ltd. and Jiangsu Carephar Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Min Ji has collaborated with several professionals in his field, including Yinlin Qin and Mei Su. These partnerships have likely enhanced his research and development efforts, leading to advancements in pharmaceutical modulation.
Conclusion
Min Ji is a distinguished inventor whose work in pharmaceutical modulation has the potential to impact the treatment of various diseases significantly. His contributions to the field are noteworthy, and his patent reflects his innovative approach to drug development.